Format

Send to

Choose Destination
J Child Neurol. 2016 Aug;31(9):1127-37. doi: 10.1177/0883073816643402. Epub 2016 Apr 19.

Novel Compound Heterozygous Mutations Expand the Recognized Phenotypes of FARS2-Linked Disease.

Author information

1
Division of Child Neurology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA walker.melissa@mgh.harvard.edu.
2
Department of Microbiology, Ohio State University, Columbus, OH, USA.
3
Division of Neuropathology, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
4
Department of Medical Genetics, Massachusetts General Hospital, Boston, MA, USA.
5
Department of Neurology, Division of Child Neurology, Massachusetts General Hospital, Boston, MA, USA.

Abstract

Mutations in mitochondrial aminoacyl-tRNA synthetases are an increasingly recognized cause of human diseases, often arising in individuals with compound heterozygous mutations and presenting with system-specific phenotypes, frequently neurologic. FARS2 encodes mitochondrial phenylalanyl transfer ribonucleic acid (RNA) synthetase (mtPheRS), perturbations of which have been reported in 6 cases of an infantile, lethal disease with refractory epilepsy and progressive myoclonus. Here the authors report the case of juvenile onset refractory epilepsy and progressive myoclonus with compound heterozygous FARS2 mutations. The authors describe the clinical course over 6 years of care at their institution and diagnostic studies including electroencephalogram (EEG), brain magnetic resonance imaging (MRI), serum and cerebrospinal fluid analyses, skeletal muscle biopsy histology, and autopsy gross and histologic findings, which include features shared with Alpers-Huttenlocher syndrome, Leigh syndrome, and a previously published case of FARS2 mutation associated infantile onset disease. The authors also present structure-guided analysis of the relevant mutations based on published mitochondrial phenylalanyl transfer RNA synthetase and related protein crystal structures as well as biochemical analysis of the corresponding recombinant mutant proteins.

KEYWORDS:

FARS2; mitochondrial tRNA synthetase; progressive myoclonus epilepsy

PMID:
27095821
PMCID:
PMC4981184
DOI:
10.1177/0883073816643402
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center